↓ Skip to main content

Dove Medical Press

STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review

Overview of attention for article published in OncoTargets and therapy, December 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
13 Mendeley
Title
STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review
Published in
OncoTargets and therapy, December 2020
DOI 10.2147/ott.s282933
Pubmed ID
Authors

Cuiyun Su, Ya Jiang, Wei Jiang, Huilin Wang, Sisi Liu, Yang Shao, Wenhua Zhao, Ruiling Ning, Qitao Yu

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 15%
Student > Doctoral Student 2 15%
Other 1 8%
Student > Ph. D. Student 1 8%
Researcher 1 8%
Other 0 0%
Unknown 6 46%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 15%
Medicine and Dentistry 2 15%
Nursing and Health Professions 1 8%
Immunology and Microbiology 1 8%
Agricultural and Biological Sciences 1 8%
Other 0 0%
Unknown 6 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2023.
All research outputs
#15,087,768
of 25,643,886 outputs
Outputs from OncoTargets and therapy
#758
of 3,013 outputs
Outputs of similar age
#260,565
of 525,529 outputs
Outputs of similar age from OncoTargets and therapy
#20
of 93 outputs
Altmetric has tracked 25,643,886 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 525,529 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.